Cargando…
CRISPR–Cas9/long-read sequencing approach to identify cryptic mutations in BRCA1 and other tumour suppressor genes
Current clinical approaches for mutation discovery are based on short sequence reads (100–300 bp) of exons and flanking splice sites targeted by multigene panels or whole exomes. Short-read sequencing is highly accurate for detection of single nucleotide variants, small indels and simple copy number...
Autores principales: | Walsh, Tom, Casadei, Silvia, Munson, Katherine M, Eng, Mary, Mandell, Jessica B, Gulsuner, Suleyman, King, Mary-Claire |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8046837/ https://www.ncbi.nlm.nih.gov/pubmed/33060287 http://dx.doi.org/10.1136/jmedgenet-2020-107320 |
Ejemplares similares
-
Likely pathogenic structural variants in genetically unsolved patients with retinitis pigmentosa revealed by long-read sequencing
por: Sano, Yusuke, et al.
Publicado: (2022) -
Conclusion of diagnostic odysseys due to inversions disrupting GLI3 and FBN1
por: Pagnamenta, Alistair T, et al.
Publicado: (2023) -
Effects of germline and somatic events in candidate BRCA-like genes on breast-tumor signatures
por: Bodily, Weston R., et al.
Publicado: (2020) -
CRISPR-Cas Controls Cryptic Prophages
por: Song, Sooyeon, et al.
Publicado: (2022) -
Evolution of CRISPR RNA recognition and processing by Cas6 endonucleases
por: Niewoehner, Ole, et al.
Publicado: (2014)